Foundation to co-host side event at Second Global Call to Action on Antimicrobial Resistance in Accra, Ghana

During the session, titled “Access and stewardship plans during antibiotic research and development” the Access to Medicine Foundation, CARB-X and GARDP will share how they guide, support and partner with pharmaceutical companies to achieve access and stewardship goals. Presentations will be followed by an open discussion related to the role of different sectors in improving access and stewardship strategies during the R&D process.

Effectively addressing drug-resistant infections requires concerted efforts across sectors, including governments, industry and civil society. For example, research funders, product development partnerships (PDPs) and pharmaceutical companies play different but fundamental roles to ensure that new antibiotics will be accessible to the patients who need them as well as that they will be used responsibly. By considering access-to-medicine barriers and stewardship needs early on in the antibiotics research and development (R&D) process, these actors can ensure that the most appropriate product features are selected. This prompt selection also allows for sufficient time to integrate these considerations into supply, registration and pricing strategies.